SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported) December 16, 2003 PHARMOS CORPORATION (Exact name of Registrant as Specified in its Charter) Nevada 0-11550 36-3207413 (State or Other Jurisdiction (Commission file Number) (IRS Employer of Incorporation) Identification No.) 99 Wood Avenue South, Suite 311, Iselin, New Jersey 08830 (Address of Principal Executive Offices) (Zip Code) Registrant's telephone number, including area code (732) 452-9556 Item 5. Other Events On December 16, 2003, Pharmos Corporation ("Pharmos") issued a press release announcing the pricing of its previously announced public offering. Pharmos will be offering 10,500,000 common shares, at a price of $2.75 per share through a firm commitment underwriting. The net proceeds of this offering to Pharmos are expected to be approximately $27 million. A copy of Pharmos' press release is attached as Exhibit 99.1 and is incorporated herein by reference. Item 7. Financial Statements and Exhibits (c) Exhibits. 99.1 Press Release dated December 16, 2003. SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized on this 16th day of December, 2003. PHARMOS CORPORATION By: /s/ Robert W. Cook ---------------------------------- Name: Robert W. Cook Title: Executive Vice President, Chief Financial Officer